Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Auditor change
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 4 Other disposition 10% owner disposed of 18,030,000 shares (other)
  16. 4 Option exercise Director acquired 21,854 shares (option exercise)
  17. 8-K Event Unregistered share sale
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 8-K Event Regulation FD disclosure
  20. 3 Insider Initial Statement of Ownership

Page 1 of 19 · 370 filings